Importantly, the proliferation and anti-tumor activity of the transferred CD8+ T cells was entirely dependent on IL-2/IL-15 signaling, as demonstrated by genetic disruption of the IL-2 receptor alpha (CD25) or beta (CD122) subunits [8]. Here, CD8A is linked to neoplasm.